Search for: "Sanofi-Aventis US Inc"
Results 81 - 100
of 160
Sorted by Relevance
|
Sort by Date
18 Feb 2011, 11:47 am
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
23 Nov 2010, 2:19 am
GmbH and Sanofi-aventis v. [read post]
18 Mar 2010, 2:30 am
Astellas Pharma US, Inc. [read post]
12 Mar 2020, 2:17 pm
Soon after that last article, a "Dear Healthcare Professional Letter" was sent out by sanofi-aventis Canada Inc., "LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions". [read post]
22 Jul 2008, 3:10 pm
Valproate is sold as Depakote by Abbott Laboratories and as Depakine by Sanofi-Aventis. [read post]
23 Nov 2011, 1:13 pm
Sanofi-aventis Canada Inc., in collaboration with Health Canada, would like to inform patients of important safety information related to the use of the heart drug Multaq (dronedarone).... (12/13/11) ______________________________________________________________________________ In mid-June 2011 drug regulators first turned their attention to cardiovascular side effects associated with the use of Multaq (dronedarone), soon after… [read post]
22 Feb 2012, 7:37 am
GmbH and Sanofi-aventis v. [read post]
7 Apr 2010, 4:30 am
– FDA’s approval letter for Orchid’s ANDA for generic Clarinex sets new 180-day exclusivity forfeiture (FDA Law Blog) Cozaar (Losartan) / Hyzaar (Hydrochlorothiazide, Losartan) – US: Rarely used exception to the first permitted commercial marketing/use PTE criterion (FDA Law Blog) Cozaar (Losartan) / Hyzaar (Hydrochlorothiazide, Losartan) – US: Generic Cozaar/Hyzaar 180-day exclusivity – Teva wins, FDA too (despite itself) in… [read post]
15 Oct 2010, 7:49 am
It’s just how Sanofi-aventis, Proctor and Gamble and Citibank stay competitive!! [read post]
29 Jun 2011, 3:34 am
Cipla (Spicy IP) Effexor (Venlafaxine) – US: Intellipharmaceutics announces settlement for its generic version of Effexor (GenericsWeb) Eloxatin (Oxaliplatin) – US: Patent infringement complaint in response to Para IV certification: Sanofi-Aventis U.S. [read post]
10 Oct 2016, 2:59 pm
Because permanent alopecia should have been announced by Sanofi-Aventis since day one, its absence from the label constituted grounds for action. [read post]
23 May 2012, 7:37 pm
Apotex, Inc. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over… [read post]
25 Jun 2010, 1:28 pm
We start with a June 24, 2010 Wall Street Journal article, "WellPoint's Data Led It To Limit Use Of Drug Boniva Article", from we learn that the largest U.S. managed care business in terms of membership, WellPoint Inc., has found through internal research that the osteoporosis drug Boniva, which is marketed by Roche Holding AG's Genentech and GlaxoSmithKline PLC, is linked to higher fracture rates than two other bisphosphonates, Actonel, marketed by… [read post]
1 Jul 2009, 7:14 am
(Patent Docs) Products Avapro (Irbesartan) – Spain: Fourth Commercial Court of Barcelona rejects preliminary injunction petition by Sanofi-Aventis and Bristol-Myers Squibb for alleged patent infringement (International Law Office) Cozaar/Hyzaar (Losartan/Hydrochlorothiazide and Losartan) –US: Teva sues FDA over generic Cozaar and Hyzaar 180-day exclusivity forfeiture and patent delisting rule (The FDA Law Blog) Eloxatin (Oxaliplatin) –… [read post]
16 Jun 2010, 3:02 pm
(Patent Docs) US: District Court M D North Carolina: $4.8 million attorneys’ fee award designed to reimburse not punish: Aventis CropScience v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Spain:… [read post]
27 Jun 2012, 9:41 am
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
